Back
LSI Industries 10K Form
Buy
56
LYTS
LSI Industries
Last Price:
20.10
Seasonality Move:
1.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-06 | 10Q | LYTS/LSI Industries Quarterly |
2024-02-06 | 10Q | LYTS/LSI Industries Quarterly |
2023-11-06 | 10Q | LYTS/LSI Industries Quarterly |
2023-05-05 | 10Q | LYTS/LSI Industries Quarterly |
2023-02-07 | 10Q | LYTS/LSI Industries Quarterly |
2022-11-04 | 10Q | LYTS/LSI Industries Quarterly |
Receive LYTS News And Ratings
See the #1 stock for the next 7 days that we like better than LYTS
LYTS Financial Statistics
Sales & Book Value
Annual Sales: | $469.64M |
---|---|
Cash Flow: | $11.09M |
Price / Cash Flow: | 15.39 |
Annual Sales: | $7.09 |
Price / Book: | 2.87 |
Profitability
EPS (TTM): | 0.79000 |
---|---|
Net Income (TTM): | $23.63M |
Gross Margin: | $133.17M |
Return on Equity: | 11.89% |
Return on Assets: | 7.5% |
LSI Industries Earnings Forecast
Key LSI Industries Financial Ratios
- The Gross Profit Margin over the past 41 years for LYTS is 28.36%.
- The Selling, General & Administrative Expenses for LYTS have been equal to 20.79% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 8.63% of Operating Income.
- The Net Earning history of LYTS is 5.32% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 24 years.
LSI Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Electrical Equipment |
Sector: | Industrials |
Current Symbol: | LYTS |
CUSIP: | 50216C |
Website: | lsicorp.com |
Debt
Debt-to-Equity Ratio: | 0.23 |
---|---|
Current Ratio: | 2.08 |
Quick Ratio: | 1.13 |
Price-to-Earnings
Trailing P/E Ratio: | 24.46 |
---|---|
Forward P/E Ratio: | 15.62 |
LYTS Technical Analysis vs Fundamental Analysis
Buy
56
LSI Industries (LYTS)
is a Buy
Is LSI Industries a Buy or a Sell?
-
LSI Industries stock is rated a Buy
The current LSI Industries [LYTS] share price is $20.12. The Score for LYTS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.